GON Group launches "A+H" IPO in Hong Kong, opening a new chapter in globalization strategy  

1. Strategic upgrade: from "one body and two wings" to "dual circulation" capital engine

GON Group has built a vertically integrated industrial ecology with the **"one body and two wings" strategy** as the core:

"One body": Based on new chemical materials, it accurately deploys high-end manufacturing, new energy and other fields through "new materials +" to create technical barriers.

Two wings:Big chemical industry: Mergers and acquisitions of Hong Kong Petrochemical, GON Chemical (Dongming) and other projects to strengthen industrial chain synergy.

Big health industry: Holding collagen leader Dongbao Bio (300239.SZ), empowering medical, beauty, food and other trillion-level markets with "collagen +".

Financial highlights, counter-trend growth: In 2024, the company's revenue will reach 19.22 billion yuan (a year-on-year increase of 10.21%), and net profit will reach 676 million yuan (a year-on-year surge of 45.18%). Profitability is firmly in the forefront of the industry, confirming the effectiveness of the strategy.

2. Why choose Hong Kong? Decoding the dual advantages of "A+H"

As an international financial center and a frontier of consumption, Hong Kong provides GON with three springboards:

-Capital financing: attract global investors to inject capital into technology research and development, green transformation and overseas mergers and acquisitions.

-Brand internationalization: With the help of the Hong Kong platform, accelerate the overseas development of collagen products in the fields of "medicine, beauty, health and food" and create a world business card for "Chinese collagen".

-ESG benchmark: benchmark international ESG disclosure standards, strengthen circular economy and low-carbon technology, and enhance the influence of global corporate responsibility.

3. Future blueprint: global closed loop of technology, ecology and services

GON Group will use Hong Kong as a fulcrum to achieve three major goals in stages:

·Technology breakthrough: promote import substitution of high-end materials, and lead the formulation of international standards in the fields of bio-based polymers, recyclable composite materials, etc.

·Industry upgrade: integrate cross-border resources, build a global ecological chain of "R&D-production-service", and deepen technical cooperation with European and American companies.

·Market expansion: With collagen as the core, expand overseas health consumer markets, aiming to cover a global collagen industry share of US$5 billion.

4. Conclusion: With capital as the sail, sail to the deep sea

GON Group's IPO in Hong Kong is not only a milestone in the capital market, but also a microcosm of the upgrade of China's manufacturing to "China's smart manufacturing". Through the "dual circulation" strategy and global vision, the company is providing a model for China's new materials and health industry to participate in international competition with its technical hard power and brand soft power.

Tags: Global IPO Strategy, A+H Shares, Hong Kong Stock Exchange, Chemical New Materials, Collagen Industry, Cross-Border Expansion, Strategic Integration, ESG Leadership